PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A 28-day randomised, double-blind, placebo-controlled trial evaluated the safety and efficacy of Khapregesic (a K. senegalensis preparation) in women aged 42-62 years [PMID:42312188].
Supplementation with Khapregesic was associated with significant and rapid improvements in menstrual pain, mood, sleep, and fatigue over 28 days [PMID:42312188].
Aqueous extract of K. senegalensis demonstrated antiepileptogenic and learning/memory-facilitating-like effects in a kainate-induced post-status epilepticus rat model [PMID:39844945].
Ethanolic stem-bark extract was investigated for its effects on oxidative stress biomarkers and gastro-integrity in Wistar rats [PMID:25386401].
Senegalenines A-C isolated from seeds exhibited antimicrobial activity against Gram-negative bacteria with MIC values less than 40 μg/ml [PMID:34581212].
Evidence summary
PubMed sources
- 1.PMID: 22306470 (2012) — Ghana's herbal market. · Journal of ethnopharmacology
- 2.PMID: 38007506 (2023) — Chromosome-scale genomes of commercially important mahoganies, Swietenia macrophylla and Khaya senegalensis. · Scientific data
- 3.PMID: 36565063 (2023) — Evaluating Khaya senegalensis for Dipeptidyl Peptidase-IV Inhibition Using in Vitro Analysis and Molecular Dynamic Simulation of Identified Bioactive Compounds. · Chemistry & biodiversity
- 4.PMID: 19136128 (2009) — Khayanolides from African mahogany Khaya senegalensis (Meliaceae): A revision. · Phytochemistry
- 5.PMID: 11711097 (1998) — limonoids from Khaya senegalensis.